MedTrace Logo

Search for a Recanalization of the Sylvian Artery Electro-Physiological Biomarker

NCT05473975 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2025-06-25

No results posted yet for this study

Summary

Early recanalization is a major prognostic factor in vascular accidents ischemic brain injury (AIC). The acute phase therapies of AIC aim to recanalization by intravenous thrombolysis and/or mechanical thrombectomy. Recanalization is identified immediately during thrombectomy by per-procedural arteriography. For the thrombolysis, only a performed MRI will validate the recanalization. This "proof of concept" study aims to identify an Electro-Encephalographic biomarker (EEG) of the recanalization in real time, the EEG being easy to set up. This biomarker will be sought during recanalization certified by thrombectomy in order to identify the window time for which the biomarker must be sought on the EEG. During this study, the identified EEG biomarker can be used to validate the recanalization during the intravenous thrombolysis in future studies

Conditions

  • AIS

Interventions

PROCEDURE

Placement of the EGG

Placement of the EGG before the beginning of the thrombectomy

Sponsors & Collaborators

  • Fondation Ophtalmologique Adolphe de Rothschild

    lead NETWORK

Principal Investigators

  • Michael OBADIA · HOPITAL FONDATION Adolphe de ROTHSCHILD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-24
Primary Completion
2025-01-23
Completion
2025-01-23

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05473975 on ClinicalTrials.gov